Xylistin 0.5MIU Injection
749,00 ₹
Аналоги Xylistin 0.5MIU Injection
Найдите более доступные аналоги и дженерики для Xylistin 0.5MIU Injection.
Активный ингредиент: Colistimethate Sodium
Описание товара
About Xylistin 0.5MIU Injection
Xylistin 0.5MIU Injection is a medication containing the active ingredient Colistimethate Sodium, classified as Antibiotic. Colistin, also known as polymyxin E, is an antibiotic medication used as a last-resort treatment for multidrug-resistant Gram-negative infections including pneumonia. These may involve bacteria such as Pseudomonas aeruginosa, carbapenem-resistant Klebsiella pneumoniae (CRKP), or Acinetobacter.
Key Benefits & Uses
- Used for: INDICATIONS AND USAGE Colistimethate for Injection, USP is indicated for the treatment of acute or chronic infections due to sensitive strains of.
- Used for: It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Colistimethate Sodium, the active ingredient in Xylistin 0.5MIU Injection, belongs to the Antibiotic class. INDICATIONS AND USAGE Colistimethate for Injection, USP is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa . Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Xylistin 0.5MIU Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Xylistin 0.5MIU Injection for extended periods without medical advice.
Найти в аптеках
Сравните местные цены и расстояние для Xylistin 0.5MIU Injection.
Оценки посетителей
Помогите другим — оцените полезность этой страницы.
Оценок пока нет — будьте первым.